伏立康唑在新兴真菌病治疗中的作用
[The role of voriconazole in the treatment of emerging mycoses].
作者信息
Pastor F Javier, Guarro Josep
机构信息
Unitat de Microbiologia, Facultat de Medicina i Ciencies de la Salut, Universitat Rovira i Virgili, 43201, Reus, Spain.
出版信息
Rev Iberoam Micol. 2007 Sep 30;24(3):228-32. doi: 10.1016/s1130-1406(07)70048-7.
Voriconazole is a broad-spectrum antifungal drug belonging to triazoles class. Recently, it has been recommended for the treatment of invasive candidiasis in non neutropenic patients. In addition, this drug has showed clinical efficacy in the treatment of fungal infections caused by Candida species other than Candida albicans, and also in several other infections caused by less common fungi, such as Aspergillus terreus, Fusarium and Scedosporium.
伏立康唑是一种属于三唑类的广谱抗真菌药物。最近，它被推荐用于治疗非中性粒细胞减少患者的侵袭性念珠菌病。此外，该药物在治疗由白色念珠菌以外的念珠菌属引起的真菌感染以及由其他不太常见的真菌（如土曲霉、镰刀菌和赛多孢子菌）引起的其他几种感染方面已显示出临床疗效。
Zotero 插件